Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Strickland

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The New England Journal of Medicine|September 16, 2024
Preoperative Chemoradiotherapy for Resectable Gastric CancerTrevor Leong, B Mark Smithers, Michael Michael, et al.
Endoscopic Ultrasound|September 24, 2021
The EUS molecular evaluation of pancreatic cancer: A prospective multicenter cohort trialSamar Masoumi-Moghaddam, Joanne Lundy, Hugh Gao, et al.
Cancer|October 16, 2013
Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trialJolie Ringash, Heather-Jane Au, Lillian L Siu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2024
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric CancerNick Pavlakis, Kohei Shitara, Katrin Sjoquist, et al.
Clinical Colorectal Cancer|January 8, 2025
AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG)Matthew E Burge, David Espinoza, Katrin Marie Sjoquist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II TrialNick Pavlakis, Katrin M Sjoquist, Andrew J Martin, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The New England Journal of Medicine|September 16, 2024
Preoperative Chemoradiotherapy for Resectable Gastric CancerTrevor Leong, B Mark Smithers, Michael Michael, et al.
Endoscopic Ultrasound|September 24, 2021
The EUS molecular evaluation of pancreatic cancer: A prospective multicenter cohort trialSamar Masoumi-Moghaddam, Joanne Lundy, Hugh Gao, et al.
Cancer|October 16, 2013
Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trialJolie Ringash, Heather-Jane Au, Lillian L Siu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 4, 2024
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric CancerNick Pavlakis, Kohei Shitara, Katrin Sjoquist, et al.
Clinical Colorectal Cancer|January 8, 2025
AGITG MONARCC: A Randomized Phase 2 Study of Panitumumab Monotherapy and Panitumumab Plus 5-Fluorouracil as First-Line Therapy for Older Patients With RAS and BRAF Wild Type Metastatic Colorectal Cancer. A Study by the Australasian Gastro-Intestinal Trials Group (AGITG)Matthew E Burge, David Espinoza, Katrin Marie Sjoquist, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II TrialNick Pavlakis, Katrin M Sjoquist, Andrew J Martin, et al.
Pageof 3